Reshaping Clot Removal in VTE
THE NEED IS NOW
Venous thromboembolism (VTE) is the third leading cause of cardiovascular death after heart attack and stroke.1 Globally, there are approximately 10 million VTE cases each year, with pulmonary embolism (PE) responsible for the majority of VTE-related deaths.1,2 Mechanical thrombectomy enables physicians to remove thrombus without reliance on lytic drugs and restore blood flow more immediately.
A COMPLETE SOLUTION
Hēlo® Thrombectomy Platform
A novel continuous aspiration thrombectomy catheter and blood return system, designed to remove clot without corking or “lollipopping,” enabling efficient pulmonary embolism treatment in a single pass through the right heart.
PATIENT TESTIMONIAL
MISSION DRIVEN INVESTORS
Other
Undisclosed
Strategics
Other
Undisclosed
Strategics
E2 and HĒLO® IN THE NEWS
References:
1. Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060-3073. doi:10.1016/S0140-6736(16)30514-1
2. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379(9828):1835-1846. doi:10.1016/S0140-6736(11)61904-1
